Free Trial

Roth Capital Reiterates "Buy" Rating for IMAX (NYSE:IMAX)

IMAX logo with Consumer Discretionary background

Roth Capital reissued their buy rating on shares of IMAX (NYSE:IMAX - Free Report) in a report published on Wednesday,Benzinga reports. Roth Capital currently has a $36.00 price target on the stock. Roth Capital also issued estimates for IMAX's Q2 2025 earnings at $0.12 EPS, FY2025 earnings at $0.91 EPS, FY2026 earnings at $1.12 EPS and FY2027 earnings at $1.16 EPS.

Other equities research analysts have also recently issued research reports about the stock. Macquarie raised their target price on shares of IMAX from $30.00 to $32.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Wedbush restated an "outperform" rating and issued a $32.00 target price on shares of IMAX in a report on Thursday, April 17th. B. Riley restated a "buy" rating and issued a $36.00 target price on shares of IMAX in a report on Friday, May 16th. Benchmark reaffirmed a "buy" rating and set a $30.00 target price on shares of IMAX in a report on Thursday, April 10th. Finally, Wells Fargo & Company reduced their target price on shares of IMAX from $32.00 to $30.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $31.70.

Get Our Latest Report on IMAX

IMAX Stock Performance

Shares of IMAX traded up $0.71 on Wednesday, hitting $26.88. 1,003,931 shares of the stock traded hands, compared to its average volume of 790,874. The company has a market capitalization of $1.44 billion, a PE ratio of 57.19, a P/E/G ratio of 1.66 and a beta of 0.80. The business has a 50 day simple moving average of $27.22 and a 200 day simple moving average of $25.49. IMAX has a one year low of $16.62 and a one year high of $29.66.

IMAX (NYSE:IMAX - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.02. IMAX had a net margin of 6.98% and a return on equity of 7.79%. The company had revenue of $86.67 million for the quarter, compared to analysts' expectations of $82.95 million. During the same quarter last year, the company posted $0.15 earnings per share. The firm's quarterly revenue was up 9.6% on a year-over-year basis. On average, equities analysts expect that IMAX will post 0.91 earnings per share for the current year.

IMAX declared that its Board of Directors has authorized a stock buyback program on Thursday, June 12th that allows the company to buyback $100.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 6.5% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its stock is undervalued.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of IMAX. US Bancorp DE lifted its stake in shares of IMAX by 60.3% during the 4th quarter. US Bancorp DE now owns 12,276 shares of the company's stock valued at $314,000 after buying an additional 4,620 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in shares of IMAX during the 4th quarter valued at $502,000. Raymond James Financial Inc. purchased a new position in shares of IMAX during the 4th quarter valued at $9,143,000. Wealthfront Advisers LLC purchased a new position in shares of IMAX during the 4th quarter valued at $217,000. Finally, Intech Investment Management LLC lifted its stake in IMAX by 116.1% in the 4th quarter. Intech Investment Management LLC now owns 21,589 shares of the company's stock worth $553,000 after purchasing an additional 11,597 shares in the last quarter. Hedge funds and other institutional investors own 93.51% of the company's stock.

About IMAX

(Get Free Report)

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.

Read More

Analyst Recommendations for IMAX (NYSE:IMAX)

Should You Invest $1,000 in IMAX Right Now?

Before you consider IMAX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.

While IMAX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines